SOPHiA GENETICS SA

SOPH

CH1125843347

Software

Market Closed - Nasdaq Other stock markets 04:00:00 2024-07-16 pm EDT			5-day change	1st Jan Change
4.8 ^USD	+4.35%		+5.26%	+1.91%

Jul. 04	Dhiti Omics Is Now Live on SOPHiA DDM	CI
Jun. 27	Guggenheim Initiates SOPHiA GENETICS at Buy With $6 Price Target	MT

SOPHiA GENETICS SA Reaffirms Revenue Guidance for the Year 2022

March 15, 2022 at 07:02 am EDT

SOPHiA GENETICS SA reaffirmed revenue guidance for the year 2022. The company expects full year revenue for 2022 to be in the range of $51.5 million to $54 million, representing growth of 27% to 33% over full year revenue for 2021.

Latest news about SOPHiA GENETICS SA

Dhiti Omics Is Now Live on SOPHiA DDM	Jul. 04	CI
Guggenheim Initiates SOPHiA GENETICS at Buy With $6 Price Target	Jun. 27	MT
Sophia Genetics S. A. Launches New Residual Acute Myeloid Application	Jun. 24	CI
Sector Update: Health Care Stocks Fall Late Afternoon	May. 29	MT
Sophia Genetics Rallies Wednesday after Partnering with Microsoft, Nvidia on Whole Genome Analytics Platform	May. 29	MT
SOPHiA GENETICS SA to Launch New Whole Genome Sequencing Capabilities	May. 29	CI
SOPHiA GENETICS Announces Instituto Mário Penna as New Customer	May. 20	CI
Transcript : SOPHiA GENETICS SA, Q1 2024 Earnings Call, May 07, 2024	May. 07
SOPHiA GENETICS SA Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 07	CI
SOPHiA GENETICS Reiterates Earnings Guidance for the Full Year 2024	May. 07	CI
Sophia Genetics Says Nigeria's Syndicate Bio Signs on to Implement Liquid Biopsy Offering	Apr. 23	MT
SOPHiA GENETICS Announces Syndicate Bio as First Liquid Biopsy Customer in Africa	Apr. 23	CI
SOPHiA GENETICS Announces Unilabs Using Its AI Technology to Detect Homologous Recombination Deficiency	Apr. 17	CI
Sophia Genetics Forms Partnership With Strand Life Sciences to Advance Diagnostic Tools	Apr. 04	MT
Sophia Genetics SA Announces Laboratorio Barnafi-Krause Is Live on the Sophia DDM? Platform	Apr. 02	CI
SOPHiA GENETICS Announces First Homologous Recombination Deficiency Customer in Canada	Mar. 20	CI
Transcript : SOPHiA GENETICS SA Presents at Barclays 26th Annual Global Healthcare Conference 2024, Mar-12-2024 through Mar-14-2024	Mar. 12
Transcript : SOPHiA GENETICS SA, Q4 2023 Earnings Call, Mar 05, 2024	Mar. 05
SOPHiA GENETICS SA Provides Earnings Guidance for 2024	Mar. 05	CI
SOPHiA GENETICS SA Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	Mar. 05	CI
North American Morning Briefing : S&P 500 Futures -2-	Mar. 05	DJ
Sophia Genetics, AstraZeneca Expand Project to Improve Access to Ovarian Cancer Testing in Spain	Feb. 07	MT
SOPHiA GENETICS and AstraZeneca Spain Commit to Increasing Ovarian Cancer Testing in Spain	Feb. 07	CI
Sophia Genetics Supports Genetic Testing in Brazil	Jan. 25	CI
SOPHiA GENETICS Enhances RareCyte Inc. Precision Biology Services Portfolio	Jan. 18	CI

Chart SOPHiA GENETICS SA

Duration

Period

More charts

Company Profile

Sophia Genetics SA is a Switzerland-based company engaged in the software publishing sector. The Company offer a cloud-based Software-as-a-Service platform - the SOPHiA DDM, which is data-driven medicine platform enabling insights from disparate, complex datasets to improve diagnosis, treatment, and drug development. The Company has offices in Switzerland, France and the United Kingdom and operates worldwide.

Sector

Software

Calendar

2024-08-05 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for SOPHiA GENETICS SA

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

4.8 USD

Average target price

8 USD

Spread / Average Target

+66.67%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Software

	1st Jan change	Capi.
SOPHIA GENETICS SA	+1.91%	314M
MICROSOFT CORPORATION	+19.54%	3,341B
CADENCE DESIGN SYSTEMS, INC.	+14.45%	85.47B
PALANTIR TECHNOLOGIES INC.	+66.98%	63.85B
DASSAULT SYSTÈMES SE	-23.12%	48.74B
THE TRADE DESK, INC.	+40.29%	49.38B
ATLASSIAN CORPORATION	-22.99%	47.68B
SEA LIMITED	+75.85%	40.9B
TAKE-TWO INTERACTIVE SOFTWARE, INC.	-4.26%	26.97B
ROBLOX CORPORATION	-9.71%	26.42B

Other Software